Gökkus K, Yazicioglu G, Sagtas E, Uyan A, Aydin A T
Department of Orthopaedics and Trauma, Antalya Memorial Hospital, Antalya, Turkey.
J Postgrad Med. 2016 Apr-Jun;62(2):126-8. doi: 10.4103/0022-3859.174160.
We present a case of polyarticular synovitis following alendronate treatment for osteoporosis. The patient had no evidence of rheumatoid arthritis, pyrophosphate arthropathy, or seronegative/seropositive arthritis. Our main aim in this study is to highlight the potential adverse effects of alendronate and to warn orthopedic surgeons about the possibility of such a side effect that might lead orthopedic surgeons to administer wrong and unnecessary treatments like arthrocentesis. The withdrawal of alendronate is found to be the treatment of choice. Alendronate should be considered as a possible cause of synovitis or polyarthritis in patients treated with this agent in the absence of any other pathology. An association between alendronate and synovitis has rarely been described in the literature. We present a patient who developed polyarticular synovitis after treatment with alendronate and responded to its withdrawal.
我们报告一例在使用阿仑膦酸钠治疗骨质疏松症后发生多关节滑膜炎的病例。该患者没有类风湿关节炎、焦磷酸关节病或血清阴性/血清阳性关节炎的证据。我们这项研究的主要目的是强调阿仑膦酸钠的潜在不良反应,并提醒骨科医生注意可能出现这种副作用的可能性,这可能会导致骨科医生进行错误且不必要的治疗,如关节穿刺术。停用阿仑膦酸钠被认为是首选治疗方法。在没有任何其他病理情况的患者中,使用该药物治疗时,应将阿仑膦酸钠视为滑膜炎或多关节炎的可能病因。阿仑膦酸钠与滑膜炎之间的关联在文献中很少被描述。我们报告一名患者在接受阿仑膦酸钠治疗后出现多关节滑膜炎,停用后病情缓解。